Published guidance, NICE advice and quality standards | Guidance

Showing 231 to 240 of 797

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Anifrolumab for treating active autoantibody-positive systemic lupus erythematosus (terminated appraisal)	TA793	8 June 2022	8 June 2022
Diroximel fumarate for treating relapsing–remitting multiple sclerosis	TA794	8 June 2022	8 June 2022
Ibrutinib for treating Waldenstrom's macroglobulinaemia	TA795	8 June 2022	8 June 2022
Filgotinib for treating moderately to severely active ulcerative colitis	TA792	1 June 2022	1 June 2022
TYRX Absorbable Antibacterial Envelope for preventing infection from cardiac implantable electronic devices (terminated appraisal)	TA790	25 May 2022	25 May 2022
Romosozumab for treating severe osteoporosis	TA791	25 May 2022	25 May 2022
Tepotinib for treating advanced non-small-cell lung cancer with MET gene alterations	TA789	18 May 2022	18 May 2022
Avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapy	TA788	11 May 2022	11 May 2022
Tucatinib with trastuzumab and capecitabine for treating HER2-positive advanced breast cancer after 2 or more anti-HER2 therapies	TA786	27 April 2022	27 April 2022
Venetoclax with low dose cytarabine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable	TA787	27 April 2022	27 April 2022